b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="plosone" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2565067/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565067/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="PLoS ONE" /><meta name="citation_title" content="HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection" /><meta name="citation_authors" content="Bahareh Vali, Feng Yun Yue, R. Brad Jones, Prameet M. Sheth, Rupert Kaul, Michael R. Betts, David Wong, Colin Kovacs, Mona Loutfy, Andrew Common, Roberta Halpenny, Mario A. Ostrowski" /><meta name="citation_date" content="2008" /><meta name="citation_issue" content="10" /><meta name="citation_volume" content="3" /><meta name="citation_doi" content="10.1371/journal.pone.0003454" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2565067/?report=abstract" /><meta name="citation_pmid" content="18941622" /><meta name="DC.Title" content="HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Public Library of Science" /><meta name="DC.Contributor" content="Bahareh Vali" /><meta name="DC.Contributor" content="Feng Yun Yue" /><meta name="DC.Contributor" content="R. Brad Jones" /><meta name="DC.Contributor" content="Prameet M. Sheth" /><meta name="DC.Contributor" content="Rupert Kaul" /><meta name="DC.Contributor" content="Michael R. Betts" /><meta name="DC.Contributor" content="David Wong" /><meta name="DC.Contributor" content="Colin Kovacs" /><meta name="DC.Contributor" content="Mona Loutfy" /><meta name="DC.Contributor" content="Andrew Common" /><meta name="DC.Contributor" content="Roberta Halpenny" /><meta name="DC.Contributor" content="Mario A. Ostrowski" /><meta name="DC.Date" content="2008" /><meta name="DC.Identifier" content="10.1371/journal.pone.0003454" /><meta name="DC.Language" content="en" /><meta property="og:title" content="HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection" /><meta property="og:type" content="article" /><meta property="og:description" content="Hepatitis C Virus (HCV)-related liver disease progresses more rapidly in individuals co-infected with Human Immunodeficiency Virus-1 (HIV), although the underlying immunologic mechanisms are unknown. We examined whether HIV-specific T-cells are identified ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2565067/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-plosone.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2565067/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2565067/pdf/pone.0003454.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1AC028E99AC5A100000000059E059E.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="archive"><a class="navlink" href="/pmc/journals/440/">PLoS One</a></li><li class="issue-page"><a class="navlink" href="/pmc/issues/171628/">v.3(10); 2008</a></li><li class="accid">PMC2565067</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div><img src="/corehtml/pmc/pmcgifs/logo-plosone.gif" alt="Logo of plosone" usemap="#logo-imagemap" /><map id="logo-imagemap" name="logo-imagemap"><area shape="rect" coords="0,0,438,55" alt="PLoS One" title="PLoS One" href="http://www.plosone.org/" ref="reftype=publisher&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="0,56,104,74" alt="View this Article" title="View this Article" href="//dx.doi.org/10.1371/journal.pone.0003454" ref="reftype=publisher&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Content%20Provider%7CArticle%7CFullText" target="pmc_ext" /><area shape="rect" coords="106,56,202,74" alt="Submit to PLoS" title="Submit to PLoS" href="http://www.plosone.org/static/checklist.action" ref="reftype=publisher&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="204,56,302,74" alt="Get E-mail Alerts" title="Get E-mail Alerts" href="http://journals.plos.org/alerts" ref="reftype=publisher&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="304,56,374,74" alt="Contact Us" title="Contact Us" href="http://www.plosone.org/static/contact.action" ref="reftype=publisher&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /><area shape="rect" coords="440,0,500,55" alt="Public Library of Science (PLoS)" title="Public Library of Science (PLoS)" href="http://www.plos.org/" ref="reftype=publisher&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CBanner&amp;TO=Publisher%7COther%7CN/A" target="pmc_ext" /></map></div> </div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">PLoS One</span>. 2008; 3(10): e3454. </span></div><div><span class="fm-vol-iss-date">Published online 2008 Oct 20. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1371%2Fjournal.pone.0003454" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1371/journal.pone.0003454</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2565067</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/18941622">18941622</a></div></div></div></div><h1 class="content-title">HIV-Specific T-Cells Accumulate in the Liver in HCV/HIV Co-Infection</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Vali%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248719921776" co-class="co-affbox">Bahareh Vali</a>,<sup>\n1\n,</sup><sup>\n&#x0002a;\n</sup> <a href="/pubmed/?term=Yue%20FY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248713172528" co-class="co-affbox">Feng Yun Yue</a>,<sup>\n2\n</sup> <a href="/pubmed/?term=Jones%20RB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248713170608" co-class="co-affbox">R. Brad Jones</a>,<sup>\n2\n</sup> <a href="/pubmed/?term=Sheth%20PM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248716424256" co-class="co-affbox">Prameet M. Sheth</a>,<sup>\n1\n</sup> <a href="/pubmed/?term=Kaul%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248716421888" co-class="co-affbox">Rupert Kaul</a>,<sup>\n1\n,</sup><sup>\n2\n</sup> <a href="/pubmed/?term=Betts%20MR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248713424080" co-class="co-affbox">Michael R. Betts</a>,<sup>\n3\n</sup> <a href="/pubmed/?term=Wong%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248756004128" co-class="co-affbox">David Wong</a>,<sup>\n4\n</sup> <a href="/pubmed/?term=Kovacs%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248715328464" co-class="co-affbox">Colin Kovacs</a>,<sup>\n5\n</sup> <a href="/pubmed/?term=Loutfy%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248715326096" co-class="co-affbox">Mona Loutfy</a>,<sup>\n5\n</sup> <a href="/pubmed/?term=Common%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248715147312" co-class="co-affbox">Andrew Common</a>,<sup>\n6\n</sup> <a href="/pubmed/?term=Halpenny%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248715144944" co-class="co-affbox">Roberta Halpenny</a>,<sup>\n5\n</sup> and  <a href="/pubmed/?term=Ostrowski%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622" class="affpopup" co-rid="_co_idm140248714237616" co-class="co-affbox">Mario A. Ostrowski</a><sup>\n1\n,</sup><sup>\n2\n,</sup><sup>\n6\n</sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140248719921776"><h3 class="no_margin">Bahareh Vali</h3><p>  <sup>1</sup>  Institute of Medical Science, Department of Medicine, University of Toronto, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Vali%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Bahareh Vali</a></div></div><div id="_co_idm140248713172528"><h3 class="no_margin">Feng Yun Yue</h3><p>  <sup>2</sup>  Department of Immunology, University of Toronto, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Yue%20FY%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Feng Yun Yue</a></div></div><div id="_co_idm140248713170608"><h3 class="no_margin">R. Brad Jones</h3><p>  <sup>2</sup>  Department of Immunology, University of Toronto, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Jones%20RB%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">R. Brad Jones</a></div></div><div id="_co_idm140248716424256"><h3 class="no_margin">Prameet M. Sheth</h3><p>  <sup>1</sup>  Institute of Medical Science, Department of Medicine, University of Toronto, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Sheth%20PM%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Prameet M. Sheth</a></div></div><div id="_co_idm140248716421888"><h3 class="no_margin">Rupert Kaul</h3><p>  <sup>1</sup>  Institute of Medical Science, Department of Medicine, University of Toronto, Toronto, Canada,   </p><p>  <sup>2</sup>  Department of Immunology, University of Toronto, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Kaul%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Rupert Kaul</a></div></div><div id="_co_idm140248713424080"><h3 class="no_margin">Michael R. Betts</h3><p>  <sup>3</sup>  Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America,   </p><div>Find articles by <a href="/pubmed/?term=Betts%20MR%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Michael R. Betts</a></div></div><div id="_co_idm140248756004128"><h3 class="no_margin">David Wong</h3><p>  <sup>4</sup>  University Health Network, University of Toronto, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Wong%20D%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">David Wong</a></div></div><div id="_co_idm140248715328464"><h3 class="no_margin">Colin Kovacs</h3><p>  <sup>5</sup>  Canadian Immunodeficiency Research Collaborative, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Kovacs%20C%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Colin Kovacs</a></div></div><div id="_co_idm140248715326096"><h3 class="no_margin">Mona Loutfy</h3><p>  <sup>5</sup>  Canadian Immunodeficiency Research Collaborative, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Loutfy%20M%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Mona Loutfy</a></div></div><div id="_co_idm140248715147312"><h3 class="no_margin">Andrew Common</h3><p>  <sup>6</sup>  St. Michael\'s Hospital, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Common%20A%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Andrew Common</a></div></div><div id="_co_idm140248715144944"><h3 class="no_margin">Roberta Halpenny</h3><p>  <sup>5</sup>  Canadian Immunodeficiency Research Collaborative, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Halpenny%20R%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Roberta Halpenny</a></div></div><div id="_co_idm140248714237616"><h3 class="no_margin">Mario A. Ostrowski</h3><p>  <sup>1</sup>  Institute of Medical Science, Department of Medicine, University of Toronto, Toronto, Canada,   </p><p>  <sup>2</sup>  Department of Immunology, University of Toronto, Toronto, Canada,   </p><p>  <sup>6</sup>  St. Michael\'s Hospital, Toronto, Canada,   </p><div>Find articles by <a href="/pubmed/?term=Ostrowski%20MA%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=18941622">Mario A. Ostrowski</a></div></div></div></div><div class="contrib-group half_rhythm fm-editor">Douglas F. Nixon, <span class="fm-role">Editor</span><sup></sup></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140248717189920_ai idm140248719921904_ai idm140248719137776_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140248717189920_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140248717189920_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140248717189920_ai" style="display:none"><div class="fm-affl" lang="en" id="aff1">  <sup>1</sup>  Institute of Medical Science, Department of Medicine, University of Toronto, Toronto, Canada,   </div><div class="fm-affl" lang="en" id="aff2">  <sup>2</sup>  Department of Immunology, University of Toronto, Toronto, Canada,   </div><div class="fm-affl" lang="en" id="aff3">  <sup>3</sup>  Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, United States of America,   </div><div class="fm-affl" lang="en" id="aff4">  <sup>4</sup>  University Health Network, University of Toronto, Toronto, Canada,   </div><div class="fm-affl" lang="en" id="aff5">  <sup>5</sup>  Canadian Immunodeficiency Research Collaborative, Toronto, Canada,   </div><div class="fm-affl" lang="en" id="aff6">  <sup>6</sup>  St. Michael\'s Hospital, Toronto, Canada,   </div><div class="fm-affl" lang="en" id="edit1">University of California San Francisco, United States of America</div><div id="cor1">&#x0002a; E-mail: <a href="mailto:dev@null" data-email="ac.otnorotu@ilav.herahab" class="oemail">ac.otnorotu@ilav.herahab</a></div><div><p id="__p1" class="p p-first-last">Conceived and designed the experiments: BV RBJ RK MB DW MAO. Performed the experiments: BV FYY. Analyzed the data: BV RBJ Ps RK MB DW MAO. Contributed reagents/materials/analysis tools: DW CK ML AC RH MAO. Wrote the paper: BV MAO.</p></div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140248717189920_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2008 Aug 26; Accepted 2008 Sep 29.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140248717189920_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> Vali et al.</div><div class="license half_rhythm">This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2565067/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="idm140248715848416" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140248715848416title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background and Aims</h3><p id="__p2" class="p p-first-last">Hepatitis C Virus (HCV)-related liver disease progresses more rapidly in individuals co-infected with Human Immunodeficiency Virus-1 (HIV), although the underlying immunologic mechanisms are unknown. We examined whether HIV-specific T-cells are identified in the liver of HCV/HIV co-infected individuals and promote liver inflammation through bystander immune responses.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Methods</h3><p id="__p3" class="p p-first-last">\n<em>Ex-vivo</em> intra-hepatic lymphocytes from HCV mono-infected and HCV/HIV co-infected individuals were assessed for immune responses to HIV and HCV antigens by polychromatic flow cytometry.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Results</h3><p id="__p4" class="p p-first-last">HCV/HIV liver biopsies had similar frequencies of lymphocytes but lower percentages of CD4<sup>&#x0002b;</sup> T-cells compared to HCV biopsies. In co-infection, intra-hepatic HIV-specific CD8<sup>&#x0002b;</sup> and CD4<sup>&#x0002b;</sup> T-cells producing IFN-&#x003b3; and TNF-&#x003b1; were detected and were comparable in frequency to those that were HCV-specific. In co-infected individuals, viral-specific CD8<sup>&#x0002b;</sup> T-cells produced more of the fibrogenic cytokine, TNF-&#x003b1;. In both mono- and co-infected individuals, intra-hepatic HCV-specific T-cells were poorly functional compared to HIV-specific T-cells. In co-infection, HAART was not associated with a reconstitution of intra-hepatic CD4<sup>&#x0002b;</sup> T-cells and was associated with reduction in both HIV and HCV-specific intra-hepatic cytokine responses.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Conclusion</h3><p id="__p5" class="p p-first-last">The accumulation of functional HIV-specific T-cells in the liver during HCV/HIV co-infection may represent a bystander role for HIV in inducing faster progression of liver disease.</p></div></div></div><div id="s1" class="tsec sec"><h2 class="head no_bottom_margin" id="s1title">Introduction</h2><p id="__p6" class="p p-first">Approximately 25&#x00025; of Human Immunodeficiency Virus-1 (HIV) infected individuals are also infected with Hepatitis C Virus (HCV) <a href="#pone.0003454-Thomas1" rid="pone.0003454-Thomas1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020955">[1]</a>. HIV adversely affects each stage of the natural history of HCV infection. Fewer individuals recover spontaneously from HCV infection when also infected with HIV <a href="#pone.0003454-Kim1" rid="pone.0003454-Kim1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020958">[2]</a>. Among those with persistent HCV infection, HIV co-infection is associated with higher HCV viremia and more rapid progression to cirrhosis and hepatocellular carcinoma <a href="#pone.0003454-Pol1" rid="pone.0003454-Pol1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020963">[3]</a>. A recent meta-analysis showed that HIV co-infection increased the risk of histological hepatic cirrhosis by two-fold and clinically decompensated liver disease by six-fold <a href="#pone.0003454-Graham1" rid="pone.0003454-Graham1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020941">[4]</a>. In addition, HCV co-infection is associated with increased incidence of HAART (highly active antiretroviral therapy) related liver injury <a href="#pone.0003454-Sulkowski1" rid="pone.0003454-Sulkowski1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020966">[5]</a>.</p><p id="__p7">The mechanisms for hepatic damage in HCV/HIV co-infection are poorly defined. Although intra-hepatic T-cell immune responses are necessary for HCV clearance, they have also been shown to play a central role in mediating hepatocellular injury by direct cytotoxicity or indirectly by releasing cytokines. In this regard, IFN-&#x003b3; has been shown to be anti-fibrogenic, whereas, TNF-&#x003b1; activates hepatic stellate cells, which induce fibrosis, and likely contributes to progression to cirrhosis <a href="#pone.0003454-Kitamura1" rid="pone.0003454-Kitamura1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020943">[6]</a>, <a href="#pone.0003454-Simeonova1" rid="pone.0003454-Simeonova1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020970">[7]</a>.</p><p id="__p8" class="p p-last">Potent and broad CD4<sup>&#x0002b;</sup> and CD8<sup>&#x0002b;</sup> T-cell immunity are important for virologic control in both HCV and HIV viral infections. <em>Ex-vivo</em> HCV-specific CD8<sup>&#x0002b;</sup> T-cell responses in peripheral blood mono-nuclear cells (PBMCs) from mono-infected individuals are generally weak <a href="#pone.0003454-Wedemeyer1" rid="pone.0003454-Wedemeyer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020938">[8]</a>. Although, peripheral HCV-specific CD4<sup>&#x0002b;</sup> and CD8<sup>&#x0002b;</sup> T-cell responses are somewhat weaker in HCV/HIV co-infected individuals <a href="#pone.0003454-Valdez1" rid="pone.0003454-Valdez1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020965">[9]</a>, similar frequencies of intra-hepatic HCV-specific responses appear to be obtained in HCV versus HCV/HIV co-infection <a href="#pone.0003454-Alatrakchi1" rid="pone.0003454-Alatrakchi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020952">[10]</a>, <a href="#pone.0003454-Graham2" rid="pone.0003454-Graham2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020946">[11]</a>. However, <em>ex-vivo</em> HIV-specific CD8<sup>&#x0002b;</sup> T-cell responses in PBMCs from HIV mono-infected individuals are about one log higher than <em>ex-vivo</em> HCV-specific responses in HCV mono-infection. In addition, impairment in cellular immune responses to HCV compared to HIV has been shown in HCV/HIV co-infection <a href="#pone.0003454-Lauer1" rid="pone.0003454-Lauer1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020968">[12]</a>. HIV-specific CD8<sup>&#x0002b;</sup> T-cells are easily detectable in blood of untreated HIV infected individuals <a href="#pone.0003454-Betts1" rid="pone.0003454-Betts1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020959">[13]</a>. Such high frequencies of HIV-specific T-cells circulating in peripheral blood led us to question whether these cells could also migrate to the liver in HCV/HIV co-infection and through bystander responses add to the inflammation induced by HCV-specific T-cells.</p></div><div id="s2" class="tsec sec"><h2 class="head no_bottom_margin" id="s2title">Materials and Methods</h2><div id="s2a" class="sec sec-first"><h3 id="s2atitle">Study participants</h3><p id="__p9" class="p p-first">HCV mono-infected and HCV/HIV co-infected individuals who required liver biopsies for work up of liver disease were recruited for the study (see <a href="#s3" rid="s3" class=" sec">Results</a> and <a href="/pmc/articles/PMC2565067/table/pone-0003454-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0003454-t001" rid-ob="ob-pone-0003454-t001" co-legend-rid=""><span>Table 1</span></a>). All study participants provided informed, written consent and the study protocol was approved by the research ethics board at the University of Toronto and St. Michael\'s Hospital. Both blood and liver biopsy samples were received from each participant.</p><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="pone-0003454-t001"><h3>Table 1</h3><!--caption a7--><div class="caption"><!--caption a8--><strong>Characteristics of HCV mono-infected and HCV/HIV co-infected individuals, untreated for HCV.</strong></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140248717042224" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">HCV mono-infected (n&#x0200a;=&#x0200a;6)</td><td colspan="2" align="left" rowspan="1">HCV/HIV-1 Co-infected</td><td align="left" rowspan="1" colspan="1">p value</td></tr><tr><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1"></td><td align="left" rowspan="1" colspan="1">not on HAART (n&#x0200a;=&#x0200a;8)</td><td align="left" rowspan="1" colspan="1">on HAART (n&#x0200a;=&#x0200a;12)</td><td align="left" rowspan="1" colspan="1"></td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Age (y, mean)</td><td align="left" rowspan="1" colspan="1">51(&#x000b1;3.5)</td><td align="left" rowspan="1" colspan="1">42(&#x000b1;5.7)</td><td align="left" rowspan="1" colspan="1">41(&#x000b1;2.8)</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">Sex (no. male)</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">8</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">HCV genotype (no. type 1)</td><td align="left" rowspan="1" colspan="1">5</td><td align="left" rowspan="1" colspan="1">7</td><td align="left" rowspan="1" colspan="1">11</td><td align="left" rowspan="1" colspan="1"></td></tr><tr><td align="left" rowspan="1" colspan="1">HCV plasma VL (log10 IU/ml, mean)</td><td align="left" rowspan="1" colspan="1">5.03&#x000b1;(0.51)&#x0002a;<sup>a</sup>\n</td><td align="left" rowspan="1" colspan="1">6.22(&#x000b1;0.12)&#x0002a;</td><td align="left" rowspan="1" colspan="1">6.3(&#x000b1;0.08)<sup>a</sup>\n</td><td align="left" rowspan="1" colspan="1">\n<sup>a</sup>&#x0002a;p&#x0003c;.05</td></tr><tr><td align="left" rowspan="1" colspan="1">HIV plasma VL (log10 copies/ml, mean)</td><td align="left" rowspan="1" colspan="1">na</td><td align="left" rowspan="1" colspan="1">6.5(&#x000b1;0.15)</td><td align="left" rowspan="1" colspan="1">1.43(&#x000b1;0.37)</td><td align="left" rowspan="1" colspan="1">p&#x0003c;.01</td></tr><tr><td align="left" rowspan="1" colspan="1">CD4 count/&#x000b5;l (mean)</td><td align="left" rowspan="1" colspan="1">na</td><td align="left" rowspan="1" colspan="1">492(&#x000b1;34.4)</td><td align="left" rowspan="1" colspan="1">599(&#x000b1;56.9)</td><td align="left" rowspan="1" colspan="1">p&#x0003e;.05</td></tr><tr><td align="left" rowspan="1" colspan="1">ALT (mean)</td><td align="left" rowspan="1" colspan="1">65(&#x000b1;13)&#x0002a;</td><td align="left" rowspan="1" colspan="1">70(&#x000b1;16)</td><td align="left" rowspan="1" colspan="1">109(&#x000b1;52)&#x0002a;</td><td align="left" rowspan="1" colspan="1">&#x0002a;p&#x0003c;.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver Biopsy Inflammation Grade (mean)</td><td align="left" rowspan="1" colspan="1">1.7(&#x000b1;0.16)</td><td align="left" rowspan="1" colspan="1">1.9(&#x000b1;0.25)</td><td align="left" rowspan="1" colspan="1">1.7(&#x000b1;0.15)</td><td align="left" rowspan="1" colspan="1">p&#x0003e;.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Liver Biopsy Fibrosis Score (mean)</td><td align="left" rowspan="1" colspan="1">3(&#x000b1;0.6)&#x0002a;</td><td align="left" rowspan="1" colspan="1">1.5(&#x000b1;0.3)&#x0002a;</td><td align="left" rowspan="1" colspan="1">2(&#x000b1;0.5)</td><td align="left" rowspan="1" colspan="1">&#x0002a;p&#x0003c;.05</td></tr><tr><td align="left" rowspan="1" colspan="1">Lymphocytes count/liver biopsy1 (mean)</td><td align="left" rowspan="1" colspan="1">43884(&#x000b1;11007)</td><td align="left" rowspan="1" colspan="1">47095(&#x000b1;7410)</td><td align="left" rowspan="1" colspan="1">59414(&#x000b1;5165)</td><td align="left" rowspan="1" colspan="1">p&#x0003e;.05</td></tr></tbody></table></div><div id="largeobj_idm140248717042224" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2565067/table/pone-0003454-t001/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><div id="nt101"><p id="__p10" class="p p-first-last">1. Normalized to 100,000 events count.</p></div><div id="nt102"><p id="__p11" class="p p-first-last">na&#x0200a;=&#x0200a;not applicabale.</p></div><div id="nt103"><p id="__p12" class="p p-first-last">no&#x0200a;=&#x0200a;number of participants.</p></div><div id="nt104"><p id="__p13" class="p p-first-last">HAART individuals were treated&#x0003e;1 year.</p></div></div></div></div><div id="s2b" class="sec"><h3 id="s2btitle">Isolation of intra-hepatic lymphocytes from liver biopsy</h3><p id="__p14" class="p p-first-last">Liver biopsy samples were washed in RPMI-1640 to remove contaminating blood lymphocytes, manually homogenized with a plastic plunger, and treated with DNase (0.002&#x00025;, Sigma) and collagenase IV (0.02&#x00025;, Sigma) for 30 minutes, stirring at 37&#x000b0;C. The digested cell suspension was filtered through a 70 &#x000b5;m strainer, washed and re-suspended in R-10 medium (10&#x00025; fetal calf serum).</p></div><div id="s2c" class="sec"><h3 id="s2ctitle">IFN-&#x003b3; ELISPOT epitope mapping in PBMCs</h3><p id="__p15" class="p p-first-last">In order to identify candidate epitope-specific responses to be detected in <em>ex-vivo</em> liver samples, we first mapped antigen-specific T-cell responses in blood against the entire HIV-1 clade-B and HCV-1a proteome using the matrix approach by IFN-&#x003b3; ELISPOT assay as described previously <a href="#pone.0003454-Sheth1" rid="pone.0003454-Sheth1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020937">[14]</a>. Mapped peptides were then pooled to evaluate hepatic responses. In order to address the possibility that differing epitopes were only targeted in the liver, we also used four peptide pools that previously were shown to target a majority of responses. These pools spanned HIV-Gag and HCV-NS3, HCV-NS4 and HCV-Core protein (2 &#x000b5;g/peptide/ml, from National Institute of Health Reagent Program). Of the HCV pools, the pool that gave the strongest ELISPOT response in PBMCs was used for hepatic cell stimulation (see below).</p></div><div id="s2d" class="sec"><h3 id="s2dtitle">\n<em>Ex-vivo</em> stimulation and intracellular staining</h3><p id="__p16" class="p p-first-last">All the extracted cells from each liver biopsy were split in three wells and stimulated on the same day as PBMCs. 1&#x000d7;10<sup>6</sup> PBMCs and liver- isolated cells were stimulated with either DMSO, HIV or HCV peptide pools as described previously<a href="#pone.0003454-Sheth1" rid="pone.0003454-Sheth1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020954">[14]</a>. HIV pools consisted of peptides that were screened by the matrix approach in that individual plus the HIV-Gag pool. Likewise, HCV pools consisted of mapped peptides plus an HCV pool that gave the strongest response in PBMCs. CD107a antibody (PE-Cy5, BD Pharmingen) was added at the time of stimulation. The following antibodies were used for staining: CD8-PE Texas-Red (Beckman Coulter), CD4-Pacific Blue (e-Bioscience), CD3- APCCY7, IFN&#x003b3;-FITC, TNF&#x003b1;-PECY7, IL2-APC, MIP-1&#x003b2;-PE (BD Bioscience), PD-1 FITC (Biolegend) and dead cell stain Aqua (Invitrogen, Molecular Probes).</p></div><div id="s2e" class="sec"><h3 id="s2etitle">Flow cytometry</h3><p id="__p17" class="p p-first-last">Cells were analyzed on a multi-color FACSAria flow cytometer (BD Biosciences). For Blood samples between 500,000 to 1,000,000 total events and for liver biopsy samples between 50,000 to 200,000 total events were collected. Data analysis was performed using FlowJo version 8.6 (Treestar Inc., San Carlos, CA). Polychromatic FlowJo data were analyzed with PESTLE software, and pie-chart graphs were generated using SPICE software (obtained from M. Roederer, National Institutes of Health, Bethesda MD).</p></div><div id="s2f" class="sec"><h3 id="s2ftitle">Tetramer Staining</h3><p id="__p18" class="p p-first-last">Multi-parameter analysis of HIV-Gag: 77&#x02013;85 (SLYNTVATL: SL9) specific CD8<sup>&#x0002b;</sup> T-cells was conducted in both blood and liver of co-infected individuals initially identified with a positive ELISPOT response to the 15-mer HIV peptide including SL9 epitope, using the corresponding tetramer (iTAg MHC Class-I tetramer, Beckman Coulter). Tetramer staining was performed prior to peptide stimulation, at room temperature for 20 minutes. Tetramer stained cells were then washed and stimulated with 10 &#x000b5;g/ml of SL9 peptide followed by ICS staining as mentioned above. Additional HIV, HCV and CMV-specific pentamer staining (Pro5 MHC class I Pentamers -Proimmune) was conducted followed by PD-1 staining.</p></div><div id="s2g" class="sec sec-last"><h3 id="s2gtitle">Statistical analysis</h3><p id="__p19" class="p p-first-last">Data were analyzed by performing two-tailed non-parametric Mann-Whitney test using GraphPad Prism version 4.00. P-values&#x02264;0.05 were considered significant.</p></div></div><div id="s3" class="tsec sec"><h2 class="head no_bottom_margin" id="s3title">Results</h2><div id="s3a" class="sec sec-first"><h3 id="s3atitle">Subject Characteristics</h3><p id="__p20" class="p p-first-last">Three groups of individuals were studied as depicted in <a href="/pmc/articles/PMC2565067/table/pone-0003454-t001/" target="table" class="fig-table-link figpopup" rid-figpopup="pone-0003454-t001" rid-ob="ob-pone-0003454-t001" co-legend-rid=""><span>Table 1</span></a>; HCV mono-infected (n&#x0200a;=&#x0200a;6), HCV/HIV co-infected who were not receiving HAART (n&#x0200a;=&#x0200a;8) and HCV/HIV co-infected who were receiving HAART for greater than one year at the time of evaluation (n&#x0200a;=&#x0200a;12). All individuals never received prior treatment for HCV and underwent liver biopsies for staging and evaluation for pegylated-interferon/ribavirin treatment. HCV/HIV co-infected individuals had higher HCV viral loads. On average, CD4 T-cell counts of HIV infected individuals were &#x0003e;400/&#x000b5;l in both groups. Of note, the mean hepatic fibrosis scores were higher in the HAART treated and mono-infected groups in this cohort, indicating that individuals in these groups had more advanced disease at the time of biopsy in this study.</p></div><div id="s3b" class="sec"><h3 id="s3btitle">Characterizing intra-hepatic lymphocytes</h3><p id="__p21" class="p p-first">Although similar frequencies of intra-hepatic lymphocytes were obtained in dual versus mono-infection, HAART-treated individuals showed a trend towards greater percentages of lymphocytes in their biopsies (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g001" rid-ob="ob-pone-0003454-g001" co-legend-rid="lgnd_pone-0003454-g001"><span>Figure 1a</span></a>). The percentage of intra-hepatic CD4<sup>&#x0002b;</sup> T-cells was significantly reduced in dual infection [31.6&#x00025;&#x000b1;13.8 for HCV vs 6.5&#x00025;&#x000b1;2.9, for HCV/HIV therapy na&#x000ef;ve, p&#x0003c;0.01], and was not associated with any improvement in HAART-treated individuals, as previously shown in the gut<a href="#pone.0003454-Guadalupe1" rid="pone.0003454-Guadalupe1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020953">[15]</a> (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g001" rid-ob="ob-pone-0003454-g001" co-legend-rid="lgnd_pone-0003454-g001"><span>Figure 1b</span></a>). However, compared to HCV mono-infected individuals the percentage of intra-hepatic CD8<sup>&#x0002b;</sup> T-cells was higher in both co-infected groups [33.8&#x00025;&#x000b1;5.5&#x00025; for HCV vs 67.3&#x00025;&#x000b1;15.5&#x00025; for HCV/HIV therapy na&#x000ef;ve vs 59.5&#x000b1;15.1&#x00025; for HCV/HIV on HAART, p&#x0003c;0.01] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g001/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g001" rid-ob="ob-pone-0003454-g001" co-legend-rid="lgnd_pone-0003454-g001"><span>Figure 1b</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0003454-g001" co-legend-rid="lgnd_pone-0003454-g001"><a href="/pmc/articles/PMC2565067/figure/pone-0003454-g001/" target="figure" rid-figpopup="pone-0003454-g001" rid-ob="ob-pone-0003454-g001"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140248722542160" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2565067_pone.0003454.g001.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0003454.g001.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2565067/bin/pone.0003454.g001.jpg" /></a></div><div id="largeobj_idm140248722542160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2565067/figure/pone-0003454-g001/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0003454-g001"><div><a class="figpopup" href="/pmc/articles/PMC2565067/figure/pone-0003454-g001/" target="figure" rid-figpopup="pone-0003454-g001" rid-ob="ob-pone-0003454-g001">Figure 1</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Characteristics of intra-hepatic lymphocytes from HCV and HCV/HIV co-infected individuals.</strong><p id="__p22">Frequencies of lymphocytes obtained from liver biopsies normalized to total live mononuclear cell count from FACS analysis are illustrated in (a) with percent composition of intra-hepatic CD4 and CD8 expressing T-cells shown in (b).</p></div></div></div></div><div id="s3c" class="sec"><h3 id="s3ctitle">Intra-hepatic viral specific immune responses</h3><p id="__p23" class="p p-first">To determine the presence of intra-hepatic viral specific T-cell responses, liver isolated cells were stimulated with HCV and HIV peptide pools. Summary data of viral specific responses are depicted in <a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>Figure 2</span></a>. In response to stimulation with HIV peptide pool, untreated co-infected individuals showed significantly higher frequencies of intra-hepatic CD4<sup>&#x0002b;</sup> T-cells producing IFN-&#x003b3;, compared to HCV mono-infected [0.16&#x000b1;0.05&#x00025; vs 0.02&#x000b1;0.01&#x00025;, p&#x0003c;0.05], and HAART-treated co-infected individuals [0.16&#x000b1;0.05&#x00025; vs 0.03&#x000b1;0.05&#x00025;, p&#x0003c;0.05] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>Figure 2a</span></a>). Untreated co-infected individuals showed a trend towards lower frequencies of intra-hepatic IFN-&#x003b3; producing CD4<sup>&#x0002b;</sup> T-cells in response to HCV peptides. Surprisingly, HAART-treated co-infected individuals had significantly reduced HCV-specific IFN-&#x003b3; producing CD4<sup>&#x0002b;</sup> T-cells when compared to untreated co-infected individuals [0.02&#x000b1;0.01&#x00025; vs 0.46&#x000b1;0.11&#x00025;, respectively, p&#x0003c;0.01] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>figure 2a</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140248712770240" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2565067_pone.0003454.g002.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0003454.g002.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2565067/bin/pone.0003454.g002.jpg" /></a></div><div id="largeobj_idm140248712770240" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0003454-g002"><div><a class="figpopup" href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002">Figure 2</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Antigen-specific cytokine production by intra-hepatic T-cells in HCV mono-infection and HCV/HIV co-infection.</strong><p id="__p24">Figure (a) represents the summary data of the percentage of intra-hepatic CD4<sup>&#x0002b;</sup> T-cells expressing IFN-&#x003b3; in response to either HCV or HIV peptide stimulation in all the three studied cohorts, with figure (b) representing the same responses by CD8<sup>&#x0002b;</sup> T-cells. Figures (c) and (d) represent the percentage of viral-specific, intra-hepatic TNF-&#x003b1; producing CD4<sup>&#x0002b;</sup> and CD8<sup>&#x0002b;</sup> T-cells respectively.</p></div></div></div><p id="__p25">Therapy na&#x000ef;ve co-infected subjects had greater IFN-&#x003b3; producing CD8<sup>&#x0002b;</sup> T-cells in response to HIV peptides compared to HCV mono-infected individuals [1.39&#x000b1;0.37&#x00025; vs 0.02&#x000b1;0.0&#x00025;, p&#x0003c;0.05], and HAART was associated with a significant reduction in the frequencies of these cells [1.39&#x000b1;0.37&#x00025; vs 0.30&#x000b1;0.26&#x00025;, p&#x0003c;0.05] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>figure 2b</span></a>). Although there was a trend for enhanced intra-hepatic CD8<sup>&#x0002b;</sup> T-cells producing IFN-&#x003b3; in response to HCV peptides in therapy-naive co-infection compared to HCV mono-infection, this was not found to be statistically significant. HAART on the other hand, was associated with a significant reduction in HCV-specific, intra-hepatic CD8<sup>&#x0002b;</sup> T-cells producing IFN-&#x003b3; [1.3&#x000b1;0.37&#x00025; vs 0.03&#x000b1;0.01&#x00025;, p&#x0003c;0.05] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>figure 2b</span></a>).</p><p id="__p26">Similarly, co-infected individuals had significantly greater intra-hepatic TNF-&#x003b1; expressing CD4<sup>&#x0002b;</sup> T-cells after HIV peptide stimulation compared to HCV mono-infected [0.2&#x000b1;0.05 vs 0.02&#x000b1;0.01, p&#x0003c;0.01], although HAART had no significant effect on their frequencies (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>Figure 2c</span></a>). HCV mono-infected individuals showed significantly higher frequencies of HCV-specific TNF-&#x003b1; producing CD4<sup>&#x0002b;</sup> T-cells compared to HAART-treated co-infected individuals [0.91&#x000b1;0.25&#x00025; for HCV vs 0.23&#x000b1;0.20 for HCV/HIV on HAART, p&#x0003c;0.01] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>figure 2c</span></a>), but did not show significant differences with the untreated co-infected group.</p><p id="__p27" class="p p-last">The therapy-na&#x000ef;ve co-infected group showed significantly higher frequencies of intra-hepatic TNF-&#x003b1; producing CD8<sup>&#x0002b;</sup> T-cells in response to both HIV-1 and HCV antigens. Both types of responses were shown to be reduced in the HAART group [HIV-specific: 0.02&#x000b1;0.01&#x00025; vs 1.08&#x000b1;0.21&#x00025; vs 0.11&#x000b1;0.06&#x00025;; HCV vs HCV/HIV vs HCV/HIV on HAART, p&#x0003c;0.01 for all], [HCV-specific: 0.59&#x000b1;0.2&#x00025; vs 1.16&#x000b1;0.19&#x00025; vs 0.20&#x000b1;0.07&#x00025;; HCV vs HCV/HIV vs HCV/HIV on HAART, p&#x0003c;0.05 for all] (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g002/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g002" rid-ob="ob-pone-0003454-g002" co-legend-rid="lgnd_pone-0003454-g002"><span>figure 2d</span></a>).</p></div><div id="s3d" class="sec"><h3 id="s3dtitle">Multi-parameter analysis of T-cell functions</h3><p id="__p28" class="p p-first">To study the functional profile of virus-specific T-cells in HCV/HIV co-infection, simultaneous expression of 5 distinct CD8<sup>&#x0002b;</sup> T-cell markers were analyzed in 3 individuals within each cohort using a previously developed multicolor flow cytometry method<a href="#pone.0003454-Betts2" rid="pone.0003454-Betts2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020960">[16]</a>. Expression levels of degranulation marker CD107a and cytokines IFN-&#x003b3;, TNF-&#x003b1; and IL-2, as well as the chemokine MIP-1&#x003b2; were simultaneously measured in response to HCV or HIV peptides in both blood and liver of each individual. <a href="/pmc/articles/PMC2565067/figure/pone-0003454-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g003" rid-ob="ob-pone-0003454-g003" co-legend-rid="lgnd_pone-0003454-g003"><span>Figure 3</span></a> depicts a representative multi-parameter analysis of CD8<sup>&#x0002b;</sup> T-cell responses in liver and blood of a therapy-na&#x000ef;ve, co-infected subject in response to HIV and HCV peptide pools. These data indicate that both HCV and HIV specific CD8<sup>&#x0002b;</sup> T-cells expressing one or more functions are detectable in the liver and blood. Compared to blood, the frequency of HIV-specific T-cells producing CD107a and IL-2 was shown to be significantly higher in the liver of therapy-na&#x000ef;ve, co-infected individuals. Consistent with previously reported data<a href="#pone.0003454-Alatrakchi1" rid="pone.0003454-Alatrakchi1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020967">[10]</a>, HCV-specific responses were compartmentalized to the liver and stronger than peripheral HCV-specific responses (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g003/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g003" rid-ob="ob-pone-0003454-g003" co-legend-rid="lgnd_pone-0003454-g003"><span>Figure 3c</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0003454-g003" co-legend-rid="lgnd_pone-0003454-g003"><a href="/pmc/articles/PMC2565067/figure/pone-0003454-g003/" target="figure" rid-figpopup="pone-0003454-g003" rid-ob="ob-pone-0003454-g003"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140248713698160" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2565067_pone.0003454.g003.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0003454.g003.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2565067/bin/pone.0003454.g003.jpg" /></a></div><div id="largeobj_idm140248713698160" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2565067/figure/pone-0003454-g003/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0003454-g003"><div><a class="figpopup" href="/pmc/articles/PMC2565067/figure/pone-0003454-g003/" target="figure" rid-figpopup="pone-0003454-g003" rid-ob="ob-pone-0003454-g003">Figure 3</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Polychromatic FACS analysis of viral-specific T cells in HCV/HIV co-infection.</strong><p id="__p29">Shown are representative FACS data of the HIV and HCV specific multi-parameter CD8<sup>&#x0002b;</sup> T-cell responses from (a) liver and (b) blood of subject OM 405, a therapy-na&#x000ef;ve HCV/HIV co-infected individual, after in vitro stimulation using pool of HIV and HCV peptides. Initial gating on forward scatter area (FSC-A) versus height (FSC-H) was used to remove doublets. The events were further gated on forward scatter (FSC) versus the dead cell marker to remove dead cells. Lymphocytes were gated on the remaining live cells on a FSC versus SSC plot. Gates on CD3<sup>&#x0002b;</sup>/CD8<sup>&#x0002b;</sup> cells were then generated. All responses are gated on a CD3<sup>&#x0002b;</sup>/CD8<sup>&#x0002b;</sup> population and presented against TNF-&#x003b1; on the x-axis. Figure (c) shows a comparison of the frequency of HIV and HCV-specific CD8<sup>&#x0002b;</sup> T-cells in the liver and blood of therapy-na&#x000ef;ve, co-infected individuals. All intra-hepatic HCV-specific responses are significantly stronger than peripheral HCV-specific responses.</p></div></div></div></div><div id="s3e" class="sec"><h3 id="s3etitle">Recognition of functional CTL, specific for the HLA-A0201-restricted HIV-SL9 epitope in HCV/HIV co-infected liver</h3><p id="__p30" class="p p-first">To determine if T-cells specific for an HIV immuno-dominant epitope are present in HCV/HIV co-infected liver, we quantified CD8<sup>&#x0002b;</sup> T-cells specific for HLA-A&#x0002a;0201-restricted SLYNTVATL (SL9) epitope in the liver of individuals with positive SL9 responses in their blood. We identified 3 co-infected HLA-A&#x0002a;0201 individuals, among them one showed a response to the SL9 epitope of HIV-Gag antigen. <a href="/pmc/articles/PMC2565067/figure/pone-0003454-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g004" rid-ob="ob-pone-0003454-g004" co-legend-rid="lgnd_pone-0003454-g004"><span>Figure 4</span></a> shows the multi-parameter analysis of tetramer positive CD8<sup>&#x0002b;</sup> T-cells in blood and liver of this therapy-na&#x000ef;ve, co-infected individual. The tetramer cytokine response pattern was shown to be different in the liver compared to blood of the same individual, with diminished intra-hepatic tetramer-specific IFN-&#x003b3; responses and an increase in both CD107a and TNF-&#x003b1; responses, with the majority of SL9 tetramer positive cells expressing these two markers.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0003454-g004" co-legend-rid="lgnd_pone-0003454-g004"><a href="/pmc/articles/PMC2565067/figure/pone-0003454-g004/" target="figure" rid-figpopup="pone-0003454-g004" rid-ob="ob-pone-0003454-g004"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140248717483072" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2565067_pone.0003454.g004.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0003454.g004.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2565067/bin/pone.0003454.g004.jpg" /></a></div><div id="largeobj_idm140248717483072" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2565067/figure/pone-0003454-g004/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0003454-g004"><div><a class="figpopup" href="/pmc/articles/PMC2565067/figure/pone-0003454-g004/" target="figure" rid-figpopup="pone-0003454-g004" rid-ob="ob-pone-0003454-g004">Figure 4</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Tetramer positive cells specific for HIV are identified in the liver in HCV/HIV co-infection.</strong><p id="__p31">Representative multi-parameter FACS plots of HIV-SLYNTVATL (SL9) tetramer positive/ CD8<sup>&#x0002b;</sup> T-cells are shown in a) blood and b) liver of a co-infected individual (OM 403). Gating scheme on tetramer positive responses are based on initial gating on responses from the tetramer negative population. Figure (c) represents the frequency of CD8<sup>&#x0002b;</sup> T-cells specific for HCV, HIV and CMV in HCV/HIV co-infected liver (OM 385). Liver isolated mononuclear cells were stained with pools of HLA-A&#x0002a;0201 and HLA-A&#x0002a;2402-restricted pentamers (Pro5 MHC class I Pentamers, Proimmune), followed by staining for cell surface markers CD3 and CD8. The following pentamers were used for each group: HCV pentamers: NS3-CINGVCWTV and NS3-KLVALGINAV; HIV pentamers: Pol-ILKEPVHGV and Gag p24-TLNAWVKVV; CMV Pentamers: pp65-NLVPMVATV and pp65-QYDPVAALF. No CD8<sup>&#x0002b;</sup> T-cells specific for CMV were detected in this co-infected liver sample. Similar findings were found in another individual (data not shown).</p></div></div></div><p id="__p32" class="p p-last">We also included CMV as a non-hepatotropic control virus in our liver analysis. Using a pool of HLA-A&#x0002a;0201- and HLA-A&#x0002a;2402-restricted, CMV-specific pentamers, we did not detect any CMV-specific CD8<sup>&#x0002b;</sup> T-cells in HCV/HIV co-infected liver, although we could readily detect them in blood (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g004/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g004" rid-ob="ob-pone-0003454-g004" co-legend-rid="lgnd_pone-0003454-g004"><span>Figure 4c</span></a>).</p></div><div id="s3f" class="sec sec-last"><h3 id="s3ftitle">Hierarchy of viral-specific CD8<sup>&#x0002b;</sup> T-cell function during HCV mono and HCV/HIV co-infection</h3><p id="__p33" class="p p-first">Using the panel of markers TNF-&#x003b1;, IFN-&#x003b3;, MIP-1&#x003b2;, IL-2, and CD107a, we characterized the ability of CD8<sup>&#x0002b;</sup> T-cells to simultaneously exert these &#x02018;functions&#x02019; in response to both HCV and HIV peptides. <a href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005" co-legend-rid="lgnd_pone-0003454-g005"><span>Figure 5</span></a> depicts a representative functional profile of virus specific CD8<sup>&#x0002b;</sup> T-cells in blood and liver during HCV/HIV co-infection (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005" co-legend-rid="lgnd_pone-0003454-g005"><span>Fig. 5a</span></a>) and HCV mono-infection (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005" co-legend-rid="lgnd_pone-0003454-g005"><span>Fig. 5b</span></a>). Analysis of co-infected subjects demonstrates a very limited functional hierarchy of HCV-specific T cells in the blood, with majority of T-cells producing one function. HIV-specific T-cells from blood had a more expanded functional hierarchy. In accordance with previous reports on HIV mono-infected individuals <a href="#pone.0003454-Betts2" rid="pone.0003454-Betts2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020949">[16]</a>, cells expressing all 5 functions were absent in the blood of co-infected subjects, mainly due to lack of IL-2 production. In co-infection, intra-hepatic CD8<sup>&#x0002b;</sup> T-cells responding to HCV peptides were within the single-responding and 2&#x0002b; populations. Intra-hepatic CD8<sup>&#x0002b;</sup> T-cell responses to HIV peptides produced a larger spectrum of responses. CD107a responding cells were represented in nearly all of the different HIV-specific populations in the liver of co-infected individuals.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="pone-0003454-g005" co-legend-rid="lgnd_pone-0003454-g005"><a href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140248718254640" class="figure"><a class="inline_block ts_canvas" href="/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=2565067_pone.0003454.g005.jpg" target="tileshopwindow"><div class="ts_bar small" title="Click on image to zoom"></div><img alt="An external file that holds a picture, illustration, etc.&#10;Object name is pone.0003454.g005.jpg" title="Click on image to zoom" class="tileshop" src="/pmc/articles/PMC2565067/bin/pone.0003454.g005.jpg" /></a></div><div id="largeobj_idm140248718254640" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_pone-0003454-g005"><div><a class="figpopup" href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005">Figure 5</a></div><!--caption a7--><div class="caption"><!--caption a8--><strong>Characterization of the functional hierarchy of viral specific CD8<sup>&#x0002b;</sup> T-cells in HCV/HIV co-infection.</strong><p id="__p34">Representative functional profiles of virus specific CD8<sup>&#x0002b;</sup> T-cells in blood and liver are depicted from an individual with (a) HCV/HIV co-infection (OM 405) and from an individual with (b) HCV mono-infection (OM 428). For multi-parameter analysis, the Boolean gating platform was used to create all of the possible combinations of functions, generating 32 response patterns for 5 of the different functions analyzed. All data are reported after background correction. Nonspecific background is shown to become extremely low when examining combinations of functions, nearly reaching 0 events for multiple functions simultaneously. This permits a very low threshold for detection of positive responses from multiple combinations. Consequently, for multi-parameter analysis, the results were thresholded based on a minimum criterion of positivity, as calculated by SPICE software and presented as the 90<sup>th</sup> percentile of negative values for each analysis. Each pie chart generated by SPICE software, represents the hierarchy of responses to either HCV or HIV antigen stimulation. For simplicity, responses are grouped by number of functions and matched to the colored bars, with black bars representing the percentage of responding cells to HIV peptides and gray bars representing the percentage of responses to HCV peptide stimulation. In all pie charts, color red represents the 5&#x0002b; responding population and the colors blue, green, turquoise, and yellow representing the 4&#x0002b;, 3&#x0002b;, 2&#x0002b;, and 1&#x0002b; populations respectively. Color-coded arcs represent the dominant marker within each pie slice, with color blue representing TNF-&#x003b1;, red for CD107-a, green for IFN-&#x003b3; and black for MIP-1&#x003b2;. Although IL-2 is included in the presentation and demonstrated by bar graphs, the software would not allow for arc colors for more than 4 responses. As a result there is no arc representative for IL-2. Figure (c) represents the average frequency of intra-hepatic viral specific responses within the pool of CD8<sup>&#x0002b;</sup> T-cell populations simultaneously expressing 2 functions or less, compared with those within the pool of populations expressing more than 2 functions simultaneously; as analyzed in 3 subjects within each cohort of HCV mono and HCV/HIV co-infected individuals. The cutoff point of simultaneous expression of more than 2 measured markers is considered to show CD8<sup>&#x0002b;</sup> T-cell poly-functionality. Figure (d) represents PD-1 levels on HIV-1 and HCV-specific T-cells from HCV/HIV Co-infected liver (OM 385). Liver cells were stained with two pools of HLA-A&#x0002a;0201-restricted pentamers (Proimmune): HCV pentamers: NS3-CINGVCWTV, NS3-KLVALGINAV and HIV pentamers: Pol-ILKEPVHGV, Gag p24-TLNAWVKVV. PD-1 gating was based on FMO (fluorescence minus one) of the control sample.</p></div></div></div><p id="__p35">As expected, HCV-specific responses in the blood of HCV mono-infected subjects were mainly single functional. The profile of HCV-specific responses in the liver of HCV mono-infected individuals showed the appearance of a very small population of 4&#x0002b; responding cells in the liver.</p><p id="__p36">We and others have considered a cutoff point of more than 2 simultaneously expressed markers to demonstrate poly-functional characteristic of responding T-cells <a href="#pone.0003454-Betts2" rid="pone.0003454-Betts2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020940">[16]</a>, <a href="#pone.0003454-Makedonas1" rid="pone.0003454-Makedonas1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020947">[17]</a>. <a href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005" co-legend-rid="lgnd_pone-0003454-g005"><span>Figure 5c</span></a> shows a comparison between average frequency of intra-hepatic viral-specific responses within the pool of CD8<sup>&#x0002b;</sup> T-cell populations expressing 2 markers or less, and those within the pool of populations expressing more than 2 markers simultaneously. For both HCV and HIV-specific CD8<sup>&#x0002b;</sup> T-cells the majority of responses had two or less functions. However, intra-hepatic HIV-specific responses demonstrated more poly-functionality, compared to HCV-specific responses either within co-infected or mono-infected individuals [0.05&#x000b1;0.01 vs 0.007&#x000b1;0.00, p&#x0003c;0.05; HIV-specific responses vs HCV-specific responses in HCV/HIV co-infected group]; [0.05&#x000b1;0.01 vs 0.01&#x000b1;0.00, p&#x0003c;0.05; HIV-specific responses in HCV/HIV co-infected group vs HCV-specific responses in HCV mono-infected group]. In summary, although viral-specific T-cells, simultaneously expressing all 5 measured markers were rarely found in the liver, intra-hepatic HIV-specific T-cells showed greater functional capacity when compared to those being HCV-specific.</p><p id="__p37" class="p p-last">Based on the recently highlighted role of PD-1 contributing to the dysfunction of T-cells in chronic viral infections, we also determined whether HIV and HCV-specific intra-hepatic T-cells differ in the degree of PD-1 expression. In an HCV/HIV co-infected liver, we found that 100&#x00025; of intra-hepatic HCV-specific CD8<sup>&#x0002b;</sup> T-cells were PD-1 positive, compared to 48.8&#x00025; of those cells that were HIV-specific (<a href="/pmc/articles/PMC2565067/figure/pone-0003454-g005/" target="figure" class="fig-table-link figpopup" rid-figpopup="pone-0003454-g005" rid-ob="ob-pone-0003454-g005" co-legend-rid="lgnd_pone-0003454-g005"><span>Figure 5d</span></a>).</p></div></div><div id="s4" class="tsec sec"><h2 class="head no_bottom_margin" id="s4title">Discussion</h2><p id="__p38" class="p p-first">This is the first study to demonstrate the presence of HIV-specific T-cells within the liver of HCV/HIV co-infected individuals. The finding of HIV-specific T-cells within liver of co-infected individuals may not altogether be surprising, given the high frequencies of HIV-specific CD8<sup>&#x0002b;</sup> T-cells found in the peripheral blood in untreated HIV infection. Nevertheless, it is surprising to find functional T-cells of such viral specificities to be accumulating in liver. In contrast, we could not detect CMV-specific T-cells in co-infected liver despite their abundance in blood indicating that different viruses target T-cells to the liver. Recent studies have demonstrated that systemic viral infections may recruit viral-specific T-cells to the liver. The significance of non-hepatotropic viral-specific T-cells that are found in liver is unclear. It has been postulated that the liver can non-selectively trap activated T-cells during any infection, and thus act as a &#x02018;sink&#x02019; or &#x02018;graveyard&#x02019;<a href="#pone.0003454-Crispe1" rid="pone.0003454-Crispe1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020956">[18]</a>, however it is unclear whether these cells are rendered anergic while traveling in the liver or contribute to inflammation and damage as a result of bystander activation. Of note, is that hepatitis has been observed in measles <a href="#pone.0003454-Khatib1" rid="pone.0003454-Khatib1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020951">[19]</a>, SARS <a href="#pone.0003454-Chan1" rid="pone.0003454-Chan1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020942">[20]</a> and in 20&#x00025; of individuals with acute HIV infection <a href="#pone.0003454-Kahn1" rid="pone.0003454-Kahn1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020957">[21]</a>. Polakos et. al.<a href="#pone.0003454-Polakos1" rid="pone.0003454-Polakos1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020964">[22]</a> found that some individuals infected with influenza-A develop transaminitis and showed in a murine influenza model that influenza-specific CD8<sup>&#x0002b;</sup> T-cells migrate to the liver and induce hepatic damage from by-stander activation. Non-hepatotropic viruses such as HIV, CMV and EBV, in general do not induce chronic hepatitis, thus, it is possible that the co-existence of hepatotropic viruses may alter the hepatic environment to allow recruitment of activated T-cells non-specifically. This could be due to an up-regulation of integrins such as ICAM-1 and VCAM-1 in hepatic sinusoids as previously shown during HCV infection <a href="#pone.0003454-Banner1" rid="pone.0003454-Banner1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020944">[23]</a> that could enhance T-cell recruitment. In this regard, Spangenberg et. al.<a href="#pone.0003454-Spangenberg1" rid="pone.0003454-Spangenberg1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020950">[24]</a> demonstrated the presence of influenza-specific T-cells in about 50&#x00025; of liver biopsies from HCV mono-infected individuals.</p><p id="__p39">There are several lines of evidence demonstrating that the liver efficiently clears many foreign pathogens, including RNA viruses. It is shown that liver is a major organ for clearing Simian Immunodeficiency Virus in rhesus monkeys <a href="#pone.0003454-Zhang1" rid="pone.0003454-Zhang1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020962">[25]</a>. There is also evidence for the detection of HIV RNA in the liver of HIV infected individuals <a href="#pone.0003454-Cao1" rid="pone.0003454-Cao1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020969">[26]</a>. These findings support the identification of HIV-specific T-cells in the liver. In HCV/HIV co-infection, it is possible that intra-hepatic HCV-specific CD4<sup>&#x0002b;</sup> T-cells become infected with HIV and recruit HIV-specific immune responses to this site. Evidence for these potential mechanisms will need further analysis on liver biopsies of co-infected individuals.</p><p id="__p40">Our analysis of liver biopsies from HCV/HIV co-infected individuals not only demonstrate that HIV-specific T-cells producing IFN-&#x003b3; and TNF-&#x003b1; are detected in the liver, but also exhibit comparable frequencies of responses to those that are HCV-specific. This observation may explain the added contribution of HIV-specific immune responses to the ongoing intra-hepatic damage induced by HCV-specific T-cell responses that are inefficient in clearing the virus. Therapy na&#x000ef;ve co-infected individuals demonstrated a higher frequency of intra-hepatic CD8<sup>&#x0002b;</sup> T-cells that produce TNF-&#x003b1; in response to both HCV and HIV antigen stimulation compared to HCV mono-infected individuals. In addition, we identified CD8<sup>&#x0002b;</sup> T-cells specific for an immunodominant HIV epitope in co-infected liver, demonstrating high frequency of TNF-&#x003b1; expression. Intra-hepatic TNF-&#x003b1; has been previously associated with liver fibrosis, and the accumulation of cells expressing this marker may explain in part the faster rate of liver disease progression found in HCV/HIV co-infection. Further comparisons of TNF-&#x003b1; responses between immunodominant HCV and other HIV epitopes in a larger cohort of individuals are warranted. Contrary to our expectation, viral-specific, intra-hepatic levels of IFN-&#x003b3; were also higher in the therapy-na&#x000ef;ve co-infected group, which would be against the expected protective role of IFN-&#x003b3;. However, we interpret this observation as a potential effect of the fibrogenic TNF-&#x003b1; to mask IFN-&#x003b3; protection. On the other hand, viral-specific T-cells are composed of several major populations with unique functional patterns. Therefore, measurement of only one or two T-cell functions may not provide a comprehensive picture of the quality of T-cell responses.</p><p id="__p41">Recent lines of evidence demonstrate the importance of the qualitative rather than quantitative characteristics of CD8<sup>&#x0002b;</sup> T-cell responses to efficient viral control <a href="#pone.0003454-Betts1" rid="pone.0003454-Betts1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020961">[13]</a>, <a href="#pone.0003454-GeaBanacloche1" rid="pone.0003454-GeaBanacloche1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020948">[27]</a>. The significance of T-cell populations simultaneously representing 5 different functions has been discussed as a hierarchical functional model in viral infections such as CMV and EBV which are effectively controlled by respective CD8<sup>&#x0002b;</sup> T-cells <a href="#pone.0003454-Betts2" rid="pone.0003454-Betts2" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020971">[16]</a>. HCV-specific CD8<sup>&#x0002b;</sup> T-cells were not poly-functional which is consistent with the notion that although HCV-specific T-cells are found in hepatic tissue, their loss of poly-functionality may be associated with inefficient control of HCV replication. HIV-specific T-cells in the liver of co-infected individuals however, simultaneously could express 4 and 5 of the measured markers. Recently, T-cell exhaustion has been related to signaling pathways through PD-1 <a href="#pone.0003454-Urbani1" rid="pone.0003454-Urbani1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020945">[28]</a>, <a href="#pone.0003454-Day1" rid="pone.0003454-Day1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020972">[29]</a>. Our analysis of PD-1 levels of antigen-specific CD8<sup>&#x0002b;</sup> T-cells from co-infected liver demonstrates higher expression of PD-1 on HCV-specific T-cells, compared to those specific for HIV, supporting the notion that the former are less functional. The observed poly-functionality of intra-hepatic HIV-specific T-cells, should have little effect on HCV replication but would further enhance the cytokine milieu induced from bystander activation, and contribute to liver damage during co-infection with HCV. In this regard, we found that the degranulation marker CD107a dominates the HIV-specific CD8<sup>&#x0002b;</sup> T-cell responses in the liver, with the majority of the responding cells expressing CD107a, a surrogate marker for the cytotoxic function of CD8<sup>&#x0002b;</sup> T-cells. Activated HIV-specific CD8<sup>&#x0002b;</sup> T-cells with the potential to degranulate could induce bystander damage. In addition, the release of chemokines such as MIP-1&#x003b2; by the same cells could also attract further lymphocytes without HCV specificity to the liver. Bystander function of these non-specific T-cells could expand the tissue damage triggered by HCV infection and ultimately activate fibrogenesis.</p><p id="__p42">We found that the frequency of CD4<sup>&#x0002b;</sup> T-cells within livers of co-infected individuals was reduced compared to HCV mono-infection. Surprisingly, HAART did not appear to reconstitute the CD4<sup>&#x0002b;</sup> T-cell population within liver. Despite this defect of CD4<sup>&#x0002b;</sup> T-cell help, comparable frequencies of HCV-specific-CD8<sup>&#x0002b;</sup> T-cells were found in co-infected livers. HAART-treated biopsies showed further reduced frequencies of HCV-specific responses. These data support previous findings that show HAART induces CD4<sup>&#x0002b;</sup> T-cell recovery but not any restoration of HCV-specific T-cell responses peripherally <a href="#pone.0003454-Dutoit1" rid="pone.0003454-Dutoit1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_666020939">[30]</a>. Further investigation is needed to clarify the role of CD4<sup>&#x0002b;</sup> T-cell help in affecting the frequencies of HCV-specific CD8<sup>&#x0002b;</sup> T-cells in HCV/HIV-1 co-infection. HAART was also associated with a reduction in frequencies of HIV-specific T-cell responses within liver, indicating that removing the HIV antigenic load may also reduce the opportunity for such cells to accumulate within hepatic tissue.</p><p id="__p43" class="p p-last">Here, we propose a novel mechanism for enhanced HCV-related liver disease progression in HIV co-infection; that of bystander activation and induced inflammation from HIV-specific T-cells accumulated in the liver. Our data however are limited in the cross-sectional nature of our cohort, the low number of analyzed liver biopsies and the narrow range of CD4<sup>&#x0002b;</sup> T-cell counts among the studied individuals. We should also acknowledge that <em>ex-vivo</em> functional T-cell capacity may not exactly reflect the situation <em>in-vivo</em>. Further studies, particularly, those which are prospective are warranted in order to understand the role that HIV-specific T-cells play in contributing to fibrosis and in particular how HAART modulates these responses.</p></div><div id="idm140248716972304" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140248716972304title">Acknowledgments</h2><div class="sec"><p id="__p44">We are grateful to the patients who contributed their time and effort to this study. We would also like to thank Ms. Dionne White for her expertise and assistance in flow cytometry and Dr. George Makedonas for SPICE and PESTLE software training. We specially thank Dr. Mario Roederer for providing us with the mentioned software.</p></div></div><div id="idm140248716971328" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140248716971328title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140248716971200"><p id="__p45" class="p p-first-last"><strong>Competing Interests: </strong>The authors have declared that no competing interests exist.</p></p><p class="fn sec" id="idm140248716970000"><p id="__p46" class="p p-first-last"><strong>Funding: </strong>Financial support for this study was obtained from CANFAR (Canadian Foundation for AIDS Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></p></div></div><div id="idm140248720342976" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140248720342976title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="pone.0003454-Thomas1">1. <span class="element-citation">Thomas DL, Shih JW, Alter HJ, Vlahov D, Cohn S, et al.  Effect of human immunodeficiency virus on hepatitis C virus infection among injecting drug users. <span><span class="ref-journal">J Infect Dis. </span>1996;<span class="ref-vol">174</span>:690\xe2\x80\x93695.</span> [<a href="/pubmed/8843204" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=Effect+of+human+immunodeficiency+virus+on+hepatitis+C+virus+infection+among+injecting+drug+users.&amp;author=DL+Thomas&amp;author=JW+Shih&amp;author=HJ+Alter&amp;author=D+Vlahov&amp;author=S+Cohn&amp;volume=174&amp;publication_year=1996&amp;pages=690-695&amp;pmid=8843204&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Kim1">2. <span class="element-citation">Kim AY, Schulze zur Wiesch J, Kuntzen T, Timm J, Kaufmann DE, et al.  Impaired hepatitis C virus-specific T cell responses and recurrent hepatitis C virus in HIV coinfection. <span><span class="ref-journal">PLoS Med. </span>2006;<span class="ref-vol">3</span>:e492.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1705826/">PMC free article</a>]</span> [<a href="/pubmed/17194190" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+Med&amp;title=Impaired+hepatitis+C+virus-specific+T+cell+responses+and+recurrent+hepatitis+C+virus+in+HIV+coinfection.&amp;author=AY+Kim&amp;author=J+Schulze+zur+Wiesch&amp;author=T+Kuntzen&amp;author=J+Timm&amp;author=DE+Kaufmann&amp;volume=3&amp;publication_year=2006&amp;pages=e492&amp;pmid=17194190&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Pol1">3. <span class="element-citation">Pol S, Lamorthe B, Thi NT, Thiers V, Carnot F, et al.  Retrospective analysis of the impact of HIV infection and alcohol use on chronic hepatitis C in a large cohort of drug users. <span><span class="ref-journal">J Hepatol. </span>1998;<span class="ref-vol">28</span>:945\xe2\x80\x93950.</span> [<a href="/pubmed/9672168" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Hepatol&amp;title=Retrospective+analysis+of+the+impact+of+HIV+infection+and+alcohol+use+on+chronic+hepatitis+C+in+a+large+cohort+of+drug+users.&amp;author=S+Pol&amp;author=B+Lamorthe&amp;author=NT+Thi&amp;author=V+Thiers&amp;author=F+Carnot&amp;volume=28&amp;publication_year=1998&amp;pages=945-950&amp;pmid=9672168&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Graham1">4. <span class="element-citation">Graham CS, Baden LR, Yu E, Mrus JM, Carnie J, et al.  Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. <span><span class="ref-journal">Clin Infect Dis. </span>2001;<span class="ref-vol">33</span>:562\xe2\x80\x93569.</span> [<a href="/pubmed/11462196" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Infect+Dis&amp;title=Influence+of+human+immunodeficiency+virus+infection+on+the+course+of+hepatitis+C+virus+infection:+a+meta-analysis.&amp;author=CS+Graham&amp;author=LR+Baden&amp;author=E+Yu&amp;author=JM+Mrus&amp;author=J+Carnie&amp;volume=33&amp;publication_year=2001&amp;pages=562-569&amp;pmid=11462196&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Sulkowski1">5. <span class="element-citation">Sulkowski MS, Thomas DL, Chaisson RE, Moore RD. Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection. <span><span class="ref-journal">Jama. </span>2000;<span class="ref-vol">283</span>:74\xe2\x80\x9380.</span> [<a href="/pubmed/10632283" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Jama&amp;title=Hepatotoxicity+associated+with+antiretroviral+therapy+in+adults+infected+with+human+immunodeficiency+virus+and+the+role+of+hepatitis+C+or+B+virus+infection.&amp;author=MS+Sulkowski&amp;author=DL+Thomas&amp;author=RE+Chaisson&amp;author=RD+Moore&amp;volume=283&amp;publication_year=2000&amp;pages=74-80&amp;pmid=10632283&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Kitamura1">6. <span class="element-citation">Kitamura K, Nakamoto Y, Akiyama M, Fujii C, Kondo T, et al.  Pathogenic roles of tumor necrosis factor receptor p55-mediated signals in dimethylnitrosamine-induced murine liver fibrosis. <span><span class="ref-journal">Lab Invest. </span>2002;<span class="ref-vol">82</span>:571\xe2\x80\x93583.</span> [<a href="/pubmed/12003998" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lab+Invest&amp;title=Pathogenic+roles+of+tumor+necrosis+factor+receptor+p55-mediated+signals+in+dimethylnitrosamine-induced+murine+liver+fibrosis.&amp;author=K+Kitamura&amp;author=Y+Nakamoto&amp;author=M+Akiyama&amp;author=C+Fujii&amp;author=T+Kondo&amp;volume=82&amp;publication_year=2002&amp;pages=571-583&amp;pmid=12003998&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Simeonova1">7. <span class="element-citation">Simeonova PP, Gallucci RM, Hulderman T, Wilson R, Kommineni C, et al.  The role of tumor necrosis factor-alpha in liver toxicity, inflammation, and fibrosis induced by carbon tetrachloride. <span><span class="ref-journal">Toxicol Appl Pharmacol. </span>2001;<span class="ref-vol">177</span>:112\xe2\x80\x93120.</span> [<a href="/pubmed/11740910" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Toxicol+Appl+Pharmacol&amp;title=The+role+of+tumor+necrosis+factor-alpha+in+liver+toxicity,+inflammation,+and+fibrosis+induced+by+carbon+tetrachloride.&amp;author=PP+Simeonova&amp;author=RM+Gallucci&amp;author=T+Hulderman&amp;author=R+Wilson&amp;author=C+Kommineni&amp;volume=177&amp;publication_year=2001&amp;pages=112-120&amp;pmid=11740910&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Wedemeyer1">8. <span class="element-citation">Wedemeyer H, He XS, Nascimbeni M, Davis AR, Greenberg HB, et al.  Impaired effector function of hepatitis C virus-specific CD8&#x0002b; T cells in chronic hepatitis C virus infection. <span><span class="ref-journal">J Immunol. </span>2002;<span class="ref-vol">169</span>:3447\xe2\x80\x933458.</span> [<a href="/pubmed/12218168" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Impaired+effector+function+of+hepatitis+C+virus-specific+CD8&#x0002b;+T+cells+in+chronic+hepatitis+C+virus+infection.&amp;author=H+Wedemeyer&amp;author=XS+He&amp;author=M+Nascimbeni&amp;author=AR+Davis&amp;author=HB+Greenberg&amp;volume=169&amp;publication_year=2002&amp;pages=3447-3458&amp;pmid=12218168&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Valdez1">9. <span class="element-citation">Valdez H, Carlson NL, Post AB, Asaad R, Heeger PS, et al.  HIV long-term non-progressors maintain brisk CD8 T cell responses to other viral antigens. <span><span class="ref-journal">Aids. </span>2002;<span class="ref-vol">16</span>:1113\xe2\x80\x931118.</span> [<a href="/pubmed/12004269" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aids&amp;title=HIV+long-term+non-progressors+maintain+brisk+CD8+T+cell+responses+to+other+viral+antigens.&amp;author=H+Valdez&amp;author=NL+Carlson&amp;author=AB+Post&amp;author=R+Asaad&amp;author=PS+Heeger&amp;volume=16&amp;publication_year=2002&amp;pages=1113-1118&amp;pmid=12004269&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Alatrakchi1">10. <span class="element-citation">Alatrakchi N, Graham CS, He Q, Sherman KE, Koziel MJ. CD8&#x0002b; cell responses to hepatitis C virus (HCV) in the liver of persons with HCV-HIV coinfection versus HCV monoinfection. <span><span class="ref-journal">J Infect Dis. </span>2005;<span class="ref-vol">191</span>:702\xe2\x80\x93709.</span> [<a href="/pubmed/15688283" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Infect+Dis&amp;title=CD8&#x0002b;+cell+responses+to+hepatitis+C+virus+(HCV)+in+the+liver+of+persons+with+HCV-HIV+coinfection+versus+HCV+monoinfection.&amp;author=N+Alatrakchi&amp;author=CS+Graham&amp;author=Q+He&amp;author=KE+Sherman&amp;author=MJ+Koziel&amp;volume=191&amp;publication_year=2005&amp;pages=702-709&amp;pmid=15688283&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Graham2">11. <span class="element-citation">Graham CS, Curry M, He Q, Afdhal N, Nunes D, et al.  Comparison of HCV-specific intrahepatic CD4&#x0002b; T cells in HIV/HCV versus HCV. <span><span class="ref-journal">Hepatology. </span>2004;<span class="ref-vol">40</span>:125\xe2\x80\x93132.</span> [<a href="/pubmed/15239095" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Comparison+of+HCV-specific+intrahepatic+CD4&#x0002b;+T+cells+in+HIV/HCV+versus+HCV.&amp;author=CS+Graham&amp;author=M+Curry&amp;author=Q+He&amp;author=N+Afdhal&amp;author=D+Nunes&amp;volume=40&amp;publication_year=2004&amp;pages=125-132&amp;pmid=15239095&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Lauer1">12. <span class="element-citation">Lauer GM, Nguyen TN, Day CL, Robbins GK, Flynn T, et al.  Human immunodeficiency virus type 1-hepatitis C virus coinfection: intraindividual comparison of cellular immune responses against two persistent viruses. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:2817\xe2\x80\x932826.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC135971/">PMC free article</a>]</span> [<a href="/pubmed/11861849" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Human+immunodeficiency+virus+type+1-hepatitis+C+virus+coinfection:+intraindividual+comparison+of+cellular+immune+responses+against+two+persistent+viruses.&amp;author=GM+Lauer&amp;author=TN+Nguyen&amp;author=CL+Day&amp;author=GK+Robbins&amp;author=T+Flynn&amp;volume=76&amp;publication_year=2002&amp;pages=2817-2826&amp;pmid=11861849&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Betts1">13. <span class="element-citation">Betts MR, Ambrozak DR, Douek DC, Bonhoeffer S, Brenchley JM, et al.  Analysis of total human immunodeficiency virus (HIV)-specific CD4(&#x0002b;) and CD8(&#x0002b;) T-cell responses: relationship to viral load in untreated HIV infection. <span><span class="ref-journal">J Virol. </span>2001;<span class="ref-vol">75</span>:11983\xe2\x80\x9311991.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC116093/">PMC free article</a>]</span> [<a href="/pubmed/11711588" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Analysis+of+total+human+immunodeficiency+virus+(HIV)-specific+CD4(&#x0002b;)+and+CD8(&#x0002b;)+T-cell+responses:+relationship+to+viral+load+in+untreated+HIV+infection.&amp;author=MR+Betts&amp;author=DR+Ambrozak&amp;author=DC+Douek&amp;author=S+Bonhoeffer&amp;author=JM+Brenchley&amp;volume=75&amp;publication_year=2001&amp;pages=11983-11991&amp;pmid=11711588&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Sheth1">14. <span class="element-citation">Sheth PM, Danesh A, Shahabi K, Rebbapragada A, Kovacs C, et al.  HIV-specific CD8&#x0002b; lymphocytes in semen are not associated with reduced HIV shedding. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">175</span>:4789\xe2\x80\x934796.</span> [<a href="/pubmed/16177128" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=HIV-specific+CD8&#x0002b;+lymphocytes+in+semen+are+not+associated+with+reduced+HIV+shedding.&amp;author=PM+Sheth&amp;author=A+Danesh&amp;author=K+Shahabi&amp;author=A+Rebbapragada&amp;author=C+Kovacs&amp;volume=175&amp;publication_year=2005&amp;pages=4789-4796&amp;pmid=16177128&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Guadalupe1">15. <span class="element-citation">Guadalupe M, Reay E, Sankaran S, Prindiville T, Flamm J, et al.  Severe CD4&#x0002b; T-cell depletion in gut lymphoid tissue during primary human immunodeficiency virus type 1 infection and substantial delay in restoration following highly active antiretroviral therapy. <span><span class="ref-journal">J Virol. </span>2003;<span class="ref-vol">77</span>:11708\xe2\x80\x9311717.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC229357/">PMC free article</a>]</span> [<a href="/pubmed/14557656" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=Severe+CD4&#x0002b;+T-cell+depletion+in+gut+lymphoid+tissue+during+primary+human+immunodeficiency+virus+type+1+infection+and+substantial+delay+in+restoration+following+highly+active+antiretroviral+therapy.&amp;author=M+Guadalupe&amp;author=E+Reay&amp;author=S+Sankaran&amp;author=T+Prindiville&amp;author=J+Flamm&amp;volume=77&amp;publication_year=2003&amp;pages=11708-11717&amp;pmid=14557656&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Betts2">16. <span class="element-citation">Betts MR, Nason MC, West SM, De Rosa SC, Migueles SA, et al.  HIV nonprogressors preferentially maintain highly functional HIV-specific CD8&#x0002b; T cells. <span><span class="ref-journal">Blood. </span>2006;<span class="ref-vol">107</span>:4781\xe2\x80\x934789.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1895811/">PMC free article</a>]</span> [<a href="/pubmed/16467198" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=HIV+nonprogressors+preferentially+maintain+highly+functional+HIV-specific+CD8&#x0002b;+T+cells.&amp;author=MR+Betts&amp;author=MC+Nason&amp;author=SM+West&amp;author=SC+De+Rosa&amp;author=SA+Migueles&amp;volume=107&amp;publication_year=2006&amp;pages=4781-4789&amp;pmid=16467198&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Makedonas1">17. <span class="element-citation">Makedonas G, Betts M. Polyfunctional analysis of human t cell responses: importance in vaccine immunogenicity and natural infection. <span><span class="ref-journal">Springer Sem Immunol. </span>2006;<span class="ref-vol">28</span>:209\xe2\x80\x93219.</span> [<a href="/pubmed/16932955" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Springer+Sem+Immunol&amp;title=Polyfunctional+analysis+of+human+t+cell+responses:+importance+in+vaccine+immunogenicity+and+natural+infection.&amp;author=G+Makedonas&amp;author=M+Betts&amp;volume=28&amp;publication_year=2006&amp;pages=209-219&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Crispe1">18. <span class="element-citation">Crispe IN, Dao T, Klugewitz K, Mehal WZ, Metz DP. The liver as a site of T-cell apoptosis: graveyard, or killing field? <span><span class="ref-journal">Immunol Rev. </span>2000;<span class="ref-vol">174</span>:47\xe2\x80\x9362.</span> [<a href="/pubmed/10807506" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Rev&amp;title=The+liver+as+a+site+of+T-cell+apoptosis:+graveyard,+or+killing+field?&amp;author=IN+Crispe&amp;author=T+Dao&amp;author=K+Klugewitz&amp;author=WZ+Mehal&amp;author=DP+Metz&amp;volume=174&amp;publication_year=2000&amp;pages=47-62&amp;pmid=10807506&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Khatib1">19. <span class="element-citation">Khatib R, Siddique M, Abbass M. Measles associated hepatobiliary disease: an overview. <span><span class="ref-journal">Infection. </span>1993;<span class="ref-vol">21</span>:112\xe2\x80\x93114.</span> [<a href="/pubmed/8491519" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Infection&amp;title=Measles+associated+hepatobiliary+disease:+an+overview.&amp;author=R+Khatib&amp;author=M+Siddique&amp;author=M+Abbass&amp;volume=21&amp;publication_year=1993&amp;pages=112-114&amp;pmid=8491519&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Chan1">20. <span class="element-citation">Chan HL, Kwan AC, To KF, Lai ST, Chan PK, et al.  Clinical significance of hepatic derangement in severe acute respiratory syndrome. <span><span class="ref-journal">World J Gastroenterol. </span>2005;<span class="ref-vol">11</span>:2148\xe2\x80\x932153.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC4305785/">PMC free article</a>]</span> [<a href="/pubmed/15810082" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=World+J+Gastroenterol&amp;title=Clinical+significance+of+hepatic+derangement+in+severe+acute+respiratory+syndrome.&amp;author=HL+Chan&amp;author=AC+Kwan&amp;author=KF+To&amp;author=ST+Lai&amp;author=PK+Chan&amp;volume=11&amp;publication_year=2005&amp;pages=2148-2153&amp;pmid=15810082&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Kahn1">21. <span class="element-citation">Kahn JO, Walker BD. Acute human immunodeficiency virus type 1 infection. <span><span class="ref-journal">N Engl J Med. </span>1998;<span class="ref-vol">339</span>:33\xe2\x80\x9339.</span> [<a href="/pubmed/9647878" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Acute+human+immunodeficiency+virus+type+1+infection.&amp;author=JO+Kahn&amp;author=BD+Walker&amp;volume=339&amp;publication_year=1998&amp;pages=33-39&amp;pmid=9647878&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Polakos1">22. <span class="element-citation">Polakos NK, Cornejo JC, Murray DA, Wright KO, Treanor JJ, et al.  Kupffer cell-dependent hepatitis occurs during influenza infection. <span><span class="ref-journal">Am J Pathol. </span>2006;<span class="ref-vol">168</span>:1169\xe2\x80\x931178; quiz 1404&#x02013;1165.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1606556/">PMC free article</a>]</span> [<a href="/pubmed/16565492" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Am+J+Pathol&amp;title=Kupffer+cell-dependent+hepatitis+occurs+during+influenza+infection.&amp;author=NK+Polakos&amp;author=JC+Cornejo&amp;author=DA+Murray&amp;author=KO+Wright&amp;author=JJ+Treanor&amp;volume=168&amp;publication_year=2006&amp;pages=1169-1178;+quiz+1404&#x02013;1165&amp;pmid=16565492&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Banner1">23. <span class="element-citation">Banner BF, Allan C, Savas L, Baker S, Barnard G, et al.  Inflammatory markers in chronic hepatitis C. <span><span class="ref-journal">Virchows Arch. </span>1997;<span class="ref-vol">431</span>:181\xe2\x80\x93187.</span> [<a href="/pubmed/9334839" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virchows+Arch&amp;title=Inflammatory+markers+in+chronic+hepatitis+C.&amp;author=BF+Banner&amp;author=C+Allan&amp;author=L+Savas&amp;author=S+Baker&amp;author=G+Barnard&amp;volume=431&amp;publication_year=1997&amp;pages=181-187&amp;pmid=9334839&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Spangenberg1">24. <span class="element-citation">Spangenberg HC, Viazov S, Kersting N, Neumann-Haefelin C, McKinney D, et al.  Intrahepatic CD8&#x0002b; T-cell failure during chronic hepatitis C virus infection. <span><span class="ref-journal">Hepatology. </span>2005;<span class="ref-vol">42</span>:828\xe2\x80\x93837.</span> [<a href="/pubmed/16175596" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Hepatology&amp;title=Intrahepatic+CD8&#x0002b;+T-cell+failure+during+chronic+hepatitis+C+virus+infection.&amp;author=HC+Spangenberg&amp;author=S+Viazov&amp;author=N+Kersting&amp;author=C+Neumann-Haefelin&amp;author=D+McKinney&amp;volume=42&amp;publication_year=2005&amp;pages=828-837&amp;pmid=16175596&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Zhang1">25. <span class="element-citation">Zhang L, Dailey PJ, Gettie A, Blanchard J, Ho DD. The liver is a major organ for clearing simian immunodeficiency virus in rhesus monkeys. <span><span class="ref-journal">J Virol. </span>2002;<span class="ref-vol">76</span>:5271\xe2\x80\x935273.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC136155/">PMC free article</a>]</span> [<a href="/pubmed/11967341" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=The+liver+is+a+major+organ+for+clearing+simian+immunodeficiency+virus+in+rhesus+monkeys.&amp;author=L+Zhang&amp;author=PJ+Dailey&amp;author=A+Gettie&amp;author=J+Blanchard&amp;author=DD+Ho&amp;volume=76&amp;publication_year=2002&amp;pages=5271-5273&amp;pmid=11967341&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Cao1">26. <span class="element-citation">Cao YZ, Dieterich D, Thomas PA, Huang YX, Mirabile M, et al.  Identification and quantitation of HIV-1 in the liver of patients with AIDS. <span><span class="ref-journal">Aids. </span>1992;<span class="ref-vol">6</span>:65\xe2\x80\x9370.</span> [<a href="/pubmed/1543567" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Aids&amp;title=Identification+and+quantitation+of+HIV-1+in+the+liver+of+patients+with+AIDS.&amp;author=YZ+Cao&amp;author=D+Dieterich&amp;author=PA+Thomas&amp;author=YX+Huang&amp;author=M+Mirabile&amp;volume=6&amp;publication_year=1992&amp;pages=65-70&amp;pmid=1543567&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-GeaBanacloche1">27. <span class="element-citation">Gea-Banacloche JC, Migueles SA, Martino L, Shupert WL, McNeil AC, et al.  Maintenance of large numbers of virus-specific CD8&#x0002b; T cells in HIV-infected progressors and long-term nonprogressors. <span><span class="ref-journal">J Immunol. </span>2000;<span class="ref-vol">165</span>:1082\xe2\x80\x931092.</span> [<a href="/pubmed/10878387" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Maintenance+of+large+numbers+of+virus-specific+CD8&#x0002b;+T+cells+in+HIV-infected+progressors+and+long-term+nonprogressors.&amp;author=JC+Gea-Banacloche&amp;author=SA+Migueles&amp;author=L+Martino&amp;author=WL+Shupert&amp;author=AC+McNeil&amp;volume=165&amp;publication_year=2000&amp;pages=1082-1092&amp;pmid=10878387&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Urbani1">28. <span class="element-citation">Urbani S, Amadei B, Tola D, Massari M, Schivazappa S, et al.  PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCV-specific CD8 exhaustion. <span><span class="ref-journal">J Virol. </span>2006;<span class="ref-vol">80</span>:11398\xe2\x80\x9311403.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1642188/">PMC free article</a>]</span> [<a href="/pubmed/16956940" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=PD-1+expression+in+acute+hepatitis+C+virus+(HCV)+infection+is+associated+with+HCV-specific+CD8+exhaustion.&amp;author=S+Urbani&amp;author=B+Amadei&amp;author=D+Tola&amp;author=M+Massari&amp;author=S+Schivazappa&amp;volume=80&amp;publication_year=2006&amp;pages=11398-11403&amp;pmid=16956940&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Day1">29. <span class="element-citation">Day CL, Kaufmann DE, Kiepiela P, Brown JA, Moodley ES, et al.  PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. <span><span class="ref-journal">Nature. </span>2006;<span class="ref-vol">443</span>:350\xe2\x80\x93354.</span> [<a href="/pubmed/16921384" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nature&amp;title=PD-1+expression+on+HIV-specific+T+cells+is+associated+with+T-cell+exhaustion+and+disease+progression.&amp;author=CL+Day&amp;author=DE+Kaufmann&amp;author=P+Kiepiela&amp;author=JA+Brown&amp;author=ES+Moodley&amp;volume=443&amp;publication_year=2006&amp;pages=350-354&amp;pmid=16921384&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="pone.0003454-Dutoit1">30. <span class="element-citation">Dutoit V, Ciuffreda D, Comte D, Gonvers JJ, Pantaleo G. Differences in HCV-specific T cell responses between chronic HCV infection and HIV/HCV co-infection. <span><span class="ref-journal">Eur J Immunol. </span>2005;<span class="ref-vol">35</span>:3493\xe2\x80\x933504.</span> [<a href="/pubmed/16304636" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=Differences+in+HCV-specific+T+cell+responses+between+chronic+HCV+infection+and+HIV/HCV+co-infection.&amp;author=V+Dutoit&amp;author=D+Ciuffreda&amp;author=D+Comte&amp;author=JJ+Gonvers&amp;author=G+Pantaleo&amp;volume=35&amp;publication_year=2005&amp;pages=3493-3504&amp;pmid=16304636&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2565067&amp;issue-id=171628&amp;journal-id=440&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--><div class="courtesy-note whole_rhythm small"><hr />Articles from <span class="acknowledgment-journal-title">PLoS ONE</span> are provided here courtesy of <strong>Public Library of Science</strong></div></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2565067/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2565067/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2565067/pdf/pone.0003454.pdf">PDF (1.3M)</a></li> | <li><a href="#" data-citationid="PMC2565067" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2565067%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2565067%2F&amp;text=HIV-Specific%20T-Cells%20Accumulate%20in%20the%20Liver%20in%20HCV%2FHIV%20Co-Infection"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2565067%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="18941622" data-aiid="2565067" data-aid="2565067" data-iid="171628" data-domainid="440" data-domain="plosone" data-accid="PMC2565067" data-md5="da414d5e46e2b6f90da0ad1ce89a223e"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T09:52:42-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc101&amp;ncbi_phid=8A1AC028E99AC5A100000000059E059E&amp;ncbi_session=8A1AC028E99B4A91_1438SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2565067%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=plosone&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2565067/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1AC028E99B4A91_1438SID /projects/PMC/PMCViewer@4.46 ptpmc101 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'